iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes - Trial NCT06348160

Timeline & Enrollment

Primary Outcome

Change in financial stress as measured by the Personal Financial Well-Being Scale© (PFW) Scale (PFW),Change in health insurance literacy as measured by The Health Insurance Literacy Measure (HILM) Measure (HILM),Change in diabetes-specific quality of life as measured by The Type 1 Diabetes and Life Young Adult (T1DAL- Young Adult) for ages 18-25 or The Type 1 Diabetes and Life (T1DAL- Adult) for Ages 26-30.,Change in transition navigation readiness as measured by the The Readiness for Emerging Adults with Diabetes Diagnosed in Youth (READDY) Navigation Subscale,Change in HbA1c levels as measured by self-collect capillary HbA1c

Summary

This research study aims to test a financial and health insurance iHERO Toolkit for young
 adults with type1 diabetes. The iHERO Toolkit was developed over one year with the type 1
 diabetes community, The Diabetes Link organization, and experts. Now, the investigators want
 to understand the impact of the iHERO Toolkit on diabetes self-management, financial stress,
 and health insurance literacy outcomes. The investigators are doing this study because it
 will help to better understand how to support health insurance and financial stress and
 improve self-management outcomes in young adults with type 1 diabetes. The investigators want
 to understand how the iHERO Toolkit helps all young adults with diabetes, but especially
 those on Medicaid and who are racially or ethnically diverse. The investigators will ask
 participants to participate at four-time points over one year. For the first time,
 participants will fill out online enrollment and demographic forms and 9 surveys. The 9
 surveys have 8-40 short questions each, estimated to take about 45 minutes. Participants will
 also be asked to complete a home A1c collection with a University Hospitals team member on
 Zoom.

ICD-10 Classifications